Authors: Paci, A Caire-Maurisier, AM Rieutord, A Brion, F Clair, P

Citation: A. Paci et al., Dual-mode gradient HPLC procedure for the simultaneous determination of chloroquine and proguanil, J PHARM B, 27(1-2), 2002, pp. 1-7

Authors: Mazel, M Clair, P Rousselle, C Vidal, P Scherrmann, JM Mathieu, D Temsamani, J

Citation: M. Mazel et al., Doxorubicin-peptide conjugates overcome multidrug resistance, ANTI-CANC D, 12(2), 2001, pp. 107-116

Authors: Rousselle, C Smirnova, M Clair, P Lefauconnier, JM Chavanieu, A Calas, B Scherrmann, JM Temsamani, J

Citation: C. Rousselle et al., Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: Saturation kinetics and specificity, J PHARM EXP, 296(1), 2001, pp. 124-131

Authors: Drin, G Mazel, M Clair, P Mathieu, D Kaczorek, M Temsamani, J

Citation: G. Drin et al., Physico-chemical requirements for cellular uptake of pAntp peptide - Role of lipid-binding affinity, EUR J BIOCH, 268(5), 2001, pp. 1304-1314

Authors: Clair, P Wiberg, K Granelli, I Bratt, IC Blanchet, G

Citation: P. Clair et al., Stability study of a new antidote drug combination (Atropine-HI-6-Prodiazepam) for treatment of organophosphate poisoning, EUR J PH SC, 9(3), 2000, pp. 259-263

Authors: Rousselle, C Clair, P Lefauconnier, JM Kaczorek, M Scherrmann, JM Temsamani, J

Citation: C. Rousselle et al., New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy, MOLEC PHARM, 57(4), 2000, pp. 679-686